ABSORB II: Seguimento de 2 anos não demonstrou superioridade do scaffold bioabsorvível eluidor de everolimus vs stent metálico eluidor everolimus em pacientes com doença arterial coronariana
Fundamentos: O stent bioabsorvível com eluição de everolimus (BVS) foi projetado para atingir resultados comparáveis ​​aos stents metálicos com eluição de drogas (DES) em...
Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...
Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...
Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...